2025 Guidance: Q4 2025 revenue expected to exceed $4.5 million, representing ~100% year-over-year growth versus Q4 2024. Full ...

On January 7, 2026, PainReform Ltd. filed a Form 6-K in the United States providing updated financial disclosure related to its acquisition of LayerBio Inc., a transaction first announced in July 2025 ...

Qnity reaffirms its full year 2025 financial guidance for Net Sales of ~$4.7B and Adjusted Pro Forma Operating EBITDA 1 of ...

OPM Director Scott Kupor's civil service reform plans have thus far been a mix of some good, some bad and some ugly. There's ...

Yesterday Minnesota Democrat Sen. Amy Klobuchar put out a statement: “Our local law enforcement, mayors, and community ...

Ondas Holdings Inc. (NASDAQ:ONDS) shares are trading higher Friday after the company raised its fiscal-year 2026 revenue ...

Qnity Electronics (NYSE: Q) appoints Mike Goss as Interim CFO after Matt Harbaugh steps down for health reasons, while ...

Keurig Dr Pepper’s €31.85 cash bid for JDE Peet’s and 2026 split into coffee and beverage companies—key brands, scale, timing ...

Allient Inc. stock analysis: long-term outperformance vs QQQ, secular tailwinds, and margin gains—yet valuation is near highs ...

It’s almost comforting to know that, no matter how much society “evolves,” Hollywood’s favorite sport—celebrity ...

Czech defence company Czechoslovak Group plans to float on Euronext in Amsterdam, it said on Wednesday, riding a wave of ...

SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...